SIBN stock forecast
Our latest prediction for SI-BONE, Inc.'s stock price was made on the Feb. 11, 2020 when the stock price was at 21.08$.
In the short term (2weeks), SIBN's stock price should underperform the market by -2.47%. During that period the price should oscillate between -9.39% and +7.62%.
In the medium term (3months), SIBN's stock price should underperform the market by -7.74%. During that period the price should oscillate between -32.37% and +22.13%.Get email alerts
About SI-BONE, Inc.
SI-BONE, Inc. is a medical device company, which engages in the research and development of minimally invasive surgical implant system. Its product, iFuse, seeks to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in San Jose, CA.
At the moment the company generates 63M USD in revenues.
On its last earning announcement, the company reported a loss of -1.39$ per share.
The book value per share is 3.69$
Three months stock forecastFeb. 11, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|